Transforming Rapid, Decentralised Diagnostics


Innovative Research Tools for High-Impact and Commercial Success

As a spin-out from two leading UK universities, we understand the challenges researchers face; time and funding constraints, as well as the struggle to secure commercial partners for translational impact. Vidiia empowers researchers with versatile tools for Laboratory, Field-Based, and Point-of-Care applications, helping you secure funding and attract commercial collaborations.

"Vidiia's Assay Accelerator and VH-Platform have enhanced the quality of our research projects and increased their commercial viability."
Dr. Averil Horton, Head of Business Development and Innovation, Brunel University

Join 8 leading UK universities already benefiting from Vidiia's:

VH-Platform & Assay Accelerator
Powerful, cost-effective solutions for research, assay development, and diagnostic testing.

Assay Accelerator

Join Our Mission: Accelerate 100 Assays by 2029

We want to collaborate with innovators like you.

Accelerating ✅: 15 Assays
🎯 Opportunities to Fast-Track Breakthrough Research left: 85

Why Partner with Vidiia?
Transform your research into real-world impact:

Fast-track your assay development with expert guidance every step of the way.

Access our Platform for streamlined validation and regulatory compliance.

Enhance funding success by generating robust, publication-ready data.

Attract commercial partnerships with proven results and increased translational impact.

Designed for Researchers, by Researchers
As a spin-out from two leading UK universities, we understand the challenges of securing funding and translating research into impact. Our Assay Accelerator was built with you in mind—providing a clear, four-stage framework designed to deliver results.

🔬 Ready to Amplify Your Research Impact?
Join us and become part of the 100 Assay Success Story.

VH-Platform

Our comprehensive suite of tools for research and testing

Choose a single tool or leverage the entire Vidiia platform

Designed by researchers for researchers, precision-driven platform transforms workflows with speed, accuracy, and versatility :

✅ Lightning-Fast Processing:

Achieve 30-second extractions and 30-minute AI-LAMP testing for rapid, reliable results.


✅ Unparalleled Accuracy:

Powered by AI, advanced algorithms, and cutting-edge machine learning with PCR comparable sensitivity and specificity


✅ Versatility Across Applications:

Ideal solutions for healthcare, veterinary science, agriculture, food safety, and environmental studies.


✅ Decentralised and Accessible:

Portable, user-friendly tools: Rapid Extraction, Lyophilized Mastermix, AI-LAMP and our intuitive App and Cloud Services bring diagnostics into the field, and Point-of-Care.

🔬 How could you transform your research and testing? – embrace the future of diagnostics with Vidiia.

How do you get involved? I's as simple as talking to a representative today to find out how partnering with Vidiia will speed up you research and create IMPACT and ROI

About Us

Revolutionising Diagnostics


Born from the need for rapid, cost-effective on-site testing during the COVID-19 pandemic, Vidiia transforms research into impactful diagnostics.

Leveraging AI-powered innovation, we aim to accelerate the development of 100 assays by 2029, making portable, affordable, and reliable testing accessible to all. Explore how we’re bridging the gap between discovery and real-world application to set new standards in diagnostic innovation.

What our customers say!

"Partnering with Vidiia has significantly de-risked commercial assay development projects enabling Universities such as the University of Surrey to advance assay/technology readiness levels on reduced investment and timeframes compared to previous commercial models. Their collaborative approach, technical expertise and commercial thinking gelled perfectly with our researcher’s scientific knowledge leading to multiple market ready solutions. I’m pleased to recommend partnering with Vidiia to any academic institution looking to transfer assays from the research lab into society."​​

Dr Will Lovegrove, University of Surrey, Director of Innovation Strategy, 2020-2024

"Vidiia has been supporting Brunel to bridge the gap between our academic research and practical applications. Their team’s professionalism and innovative approach to developing assays through their accelerator and AI Diagnostics platform have not only enhanced the quality of our projects but also increased their commercial viability. Working with Vidiia has been insightful for our technology transfer department, providing the support we needed to bring our discoveries to the forefront."​

Dr Averil Horton, Brunel University Head, Business Development and Innovation.

VIDIIA News

Case study of Surrey
Brunel University case study
TB in Ghana